At the international trade fair BIOPROM 2025 in Gelendzhik, Russian Deputy Prime Minister visited Pakistan’s national pavilion, expressing strong appreciation for the country’s growing strengths in the pharmaceutical and biotech sectors. This pavilion was set up by the Small and Medium Enterprises Development Authority (SMEDA) in cooperation with the Trade Development Authority of Pakistan (TDAP).

The pavilion was inaugurated under a special initiative led by national leadership to boost Pakistan’s SMEs in industries related to pharmaceuticals, food, herbal products, cosmetics, and wellness. Several well-known Pakistani brands were featured, showing manufacturing quality and innovation in products shipped locally and internationally.

Officials at the pavilion discussed ways to deepen trade ties and forge business-to-business partnerships. Representatives from Pakistan and Russia identified potential for collaboration in R&D, product development, supply chains, and regulatory alignment. The goal is to open up new export channels for Pakistani firms and make biotech and health-based products more competitive in foreign markets.

Pakistan used this opportunity to present its export ambitions to the Russian market. Emphasis was placed on highlighting the capacity of local SMEs to meet international standards in quality and compliance. Pakistani enterprises hope this exposure will lead to orders, contracts, and joint ventures.

This event is part of Pakistan’s broader trade diversification strategy. By entering non-traditional markets like Russia, the country aims to reduce dependency on usual export destinations, increase foreign exchange earnings, and encourage more value-added exports.

The Russian Deputy Prime Minister’s visit reinforces shared interest in economic cooperation. It sends a signal that the Russian side is open to partnerships in pharmaceuticals, biotechnology, and allied industries where Pakistan has demonstrated growing potential.

If Pakistan’s SMEs can harness this momentum, maintain quality, ensure regulatory compliance, and deliver consistently, they could unlock significant export growth. The path ahead will require investment, logistics improvements, and strong coordination among government agencies, producers, and foreign counterparts.

This visit marks an important step toward expanding Pakistan’s trade footprint, especially in high-potential sectors like biotech and pharmaceuticals, and toward deepening ties with new markets.